Pharmacology of Recombinant or Genetically Engineered Drugs
Kamal Kishore1★, Pawan Krishan2★ Corresponding author
- 1Departments of Pharmacy, M.J.P. Rohilkhand University, Bareilly-243006, Uttar Pradesh, INDIA.
- 2Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala-147002, Punjab,, INDIA.
CORRESPONDENCE
Kamal Kishore
Departments of Pharmacy, M.J.P. Rohilkhand University, Bareilly-243006, Uttar Pradesh, INDIA.
Volume 1, Issue 2 · pp. 141–150 · PUBLISHED · DOI: 10.4103/0975-1483.55747
ABSTRACT
Recombinant technology or genetic engineering is a modern method used for the synthesis of therapeutic agents. The central theme of recombinant technology is the process of gene cloning which consists of the production of a deÞ ned fragment of DNA and its propagation and ampliÞ cation in a suitable host cell. Drugs developed by recombinant technology or genetic engineering are known as biologics, biopharmaceuticals, recombinant DNA expressed products, bioengineered, or genetically engineered drugs. A current list of various products developed by recombinant technology includes erythropoietin, coagulation modulators, enzymes, hormones, interferons, interleukins, granulocyte colony-stimulating factors, anti-rheumatoid drugs, and various other agents like TNF, becaplermin, hepatitis-B vaccine, antibodies etc. This article provides general as well as recent pharmacological information on different aspects of recombinant drugs that may be useful for their better understanding by users and health care professionals.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Kishore, K., & Krishan, P. (). Pharmacology of Recombinant or Genetically Engineered Drugs. Journal of Young Pharmacists, 1(2), 141–150. https://doi.org/10.4103/0975-1483.55747